Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00560235 · ClinicalTrials.gov registry record · Phase 1
Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 138
- Enrollment target
NCT00560235 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 138 participants.
The verdict
NCT00560235, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 138 participants
- Enrollment target
Study Summary
Define the efficacy of CP-751,871 in patients with Ewing's sarcoma family of tumors
Interventions
- DRUG CP-751,871
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2008-03 |
| Est. Completion | 2012-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00560235
The ClinicalTrials.gov registry entry for NCT00560235 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CP-751,871 is the first listed.
NCT00560235 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00560235 about?
NCT00560235 is a clinical study titled "Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors". Define the efficacy of CP-751,871 in patients with Ewing's sarcoma family of tumors
What is the current status of trial NCT00560235?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 138 participants. The study started on 2008-03. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00560235?
The interventions under investigation include: CP-751,871 (DRUG).
Who is sponsoring clinical trial NCT00560235?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.